Pharmaceutical - Publications - Faculty & Research

In 2002, a handful of entrepreneurs began to ship drugs from Canada into the United States, taking advantage of regulatory and price differentials across the neighboring countries. Using the Internet and a low-cost network of Canadian pharmacies, firms like Rx Depot... View Details

Keywords: Courts and Trials; Entrepreneurship; Intellectual Property; Laws and Statutes; Pharmaceutical Industry; Canada; United States

Citation

Find at Harvard

2003
Chapter

La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971

By: Arthur A. Daemmrich

Keywords: History; Courts and Trials; Government Legislation; Health Disorders; Pharmaceutical Industry

Citation

May 2002 (Revised October 2005)
Case

Marketing Antidepressants: Prozac and Paxil

By: Youngme E. Moon and Kerry Herman

Describes the marketing of Prozac and Paxil, two of the best-selling mental health drugs in history. Set in 2001, several months before the expiration of Prozac's patent, Eli Lilly (Prozac's manufacturer) and GlaxoSmithKline (Paxil's manufacturer) must decide how to... View Details

Keywords: Patents; Product Positioning; Competition; Ethics; Value; Health Care and Treatment; Brands and Branding; Pharmaceutical Industry; United States

Citation

Educators

Purchase

April 2002
Supplement

Grey Warner, Merck Latin America

By: Michael Beer

Grey Warner, the vice president of Merck's Latin America region, discusses the challenges raised in the case and the lessons learned. View Details

Keywords: Strategic Planning; Values and Beliefs; Change Management; Problems and Challenges; Management Teams; Pharmaceutical Industry; Latin America

Citation

Purchase

February 2001 (Revised July 2006)
Case

Discovering the Future: R&D Strategy at Merck

By: Gary P. Pisano

Given explosive growth in technologies for drug discovery, how does Merck remain competitive in an industry that is fragmented and continues to consolidate? View Details

Keywords: Competitive Strategy; Research and Development; Pharmaceutical Industry

Citation

Educators

Purchase

May 1987
Teaching Note

Eli Lilly and Co. (A) and (B), Teaching Note

By: William J. Bruns Jr.

Keywords: Pharmaceutical Industry

Citation

June 1999 (Revised October 1999)
Case

Eli Lilly, 1998 (A): Strategic Challenges

By: Michael Y. Yoshino and Thomas W. Malnight

Deals with key strategic challenges facing Eli Lilly, a highly successful U.S.-based drug company. View Details

Keywords: Problems and Challenges; Strategy; Pharmaceutical Industry

Citation

Educators

Purchase

June 1998
Supplement

MBA Integrative Exercise: Competition & Strategy, April 1998 , Video

By: Carin-Isabel Knoop

Daniel Vasella, President of Novartis AG, discusses the situation in Indonesia and his ideas of what Suharto should do in the spring of 1998. Drummond Paris, Regional Pharma Head Asia/Pacific, Novartis AG, discusses the opportunities for Novartis in Indonesia and also... View Details

Keywords: Competitive Strategy; Pharmaceutical Industry; Indonesia

Citation

Purchase

March 1993
Supplement

Burroughs Wellcome and AZT (C)

By: Willis M. Emmons III

Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details

Keywords: Health Pandemics; Multinational Firms and Management; Financial Statements; Pharmaceutical Industry; United States

Citation

Purchase

March 1993
Supplement

Burroughs Wellcome and AZT (B)

By: Willis M. Emmons III

Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details